• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型嘧啶衍生物的合成及针对 COVID-19 的分子对接研究。

Synthesis and Molecular Docking Study of Novel Pyrimidine Derivatives against COVID-19.

机构信息

Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21551, Saudi Arabia.

Photochemistry Department (Synthetic Unit), National Research Centre, Dokki, Giza 12622, Egypt.

出版信息

Molecules. 2023 Jan 11;28(2):739. doi: 10.3390/molecules28020739.

DOI:10.3390/molecules28020739
PMID:36677798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9863666/
Abstract

A novel series of pyrido[2,3-]pyrimidines; pyrido[3,2-][1,3,4]triazolo; and tetrazolo[1,5-]pyrimidines were synthesized via different chemical transformations starting from pyrazolo[3,4-]pyridin-6-yl)-,-dimethylcarbamimidic chloride (prepared from the reaction of -aminonitrile and phosogen iminiumchloride). The structures of the newly synthesized compounds were elucidated based on spectroscopic data and elemental analyses. Designated compounds are subjected for molecular docking by using Auto Dock Vina software in order to evaluate the antiviral potency for the synthesized compounds against SARS-CoV-2 (2019-nCoV) main protease M . The antiviral activity against SARS-CoV-2 showed that tested compounds , , and had the most promising antiviral activity with lower IC values compared to Lopinavir, "the commonly used protease inhibitor". Both in silico and in vitro results are in agreement.

摘要

新型吡咯并[2,3-]嘧啶、吡咯并[3,2-][1,3,4]三唑和四唑并[1,5-]嘧啶系列化合物是通过不同的化学转化从吡唑并[3,4-]吡啶-6-基)-,-二甲基碳酰胺基氯(由-氨基腈和磷酰亚胺氯反应制备)开始合成的。根据光谱数据和元素分析确定了新合成化合物的结构。通过 Auto Dock Vina 软件对指定化合物进行分子对接,以评估合成化合物对 SARS-CoV-2(2019-nCoV)主要蛋白酶 M 的抗病毒效力。对 SARS-CoV-2 的抗病毒活性表明,与洛匹那韦(常用的蛋白酶抑制剂)相比,测试化合物 、 和 具有最有前途的抗病毒活性,IC 值更低。体内和体外结果一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/da182791bd06/molecules-28-00739-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/5f30c53852d1/molecules-28-00739-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/ecb2478c03cb/molecules-28-00739-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/d439d4a1e93f/molecules-28-00739-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/94de0f643043/molecules-28-00739-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/2c5bb1d60f9c/molecules-28-00739-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/551ac17e3f86/molecules-28-00739-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/5af962fa50f5/molecules-28-00739-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/950f622e338e/molecules-28-00739-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/da182791bd06/molecules-28-00739-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/5f30c53852d1/molecules-28-00739-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/ecb2478c03cb/molecules-28-00739-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/d439d4a1e93f/molecules-28-00739-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/94de0f643043/molecules-28-00739-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/2c5bb1d60f9c/molecules-28-00739-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/551ac17e3f86/molecules-28-00739-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/5af962fa50f5/molecules-28-00739-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/950f622e338e/molecules-28-00739-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d21/9863666/da182791bd06/molecules-28-00739-g004.jpg

相似文献

1
Synthesis and Molecular Docking Study of Novel Pyrimidine Derivatives against COVID-19.新型嘧啶衍生物的合成及针对 COVID-19 的分子对接研究。
Molecules. 2023 Jan 11;28(2):739. doi: 10.3390/molecules28020739.
2
Synthesis, Docking Study of Some Novel Chromeno[4',3'-b]Pyrano [6,5-d]Pyrimidine Derivatives Against COVID-19 Main Protease (Mpro) (6LU7, 6M03).合成、对接研究一些新型色烯并[4',3'-b]吡喃并[6,5-d]嘧啶衍生物对 COVID-19 主蛋白酶(Mpro)(6LU7,6M03)的抑制作用。
Curr Comput Aided Drug Des. 2024;20(5):551-563. doi: 10.2174/1573409919666230529125038.
3
Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M and PL.绿色高效一锅三步法合成新型类药性呋[2,3-d]嘧啶作为 SARS-CoV-2 M 和 PL 的潜在活性位点抑制剂和变构热点调节剂。
Bioorg Chem. 2023 Jun;135:106390. doi: 10.1016/j.bioorg.2023.106390. Epub 2023 Jan 28.
4
1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates.1,2,4-三唑并[1,5-a]嘧啶-7-酮类化合物作为新型 SARS-CoV-2 主蛋白酶抑制剂:用于潜在 COVID-19 候选药物的计算机筛选和分子动力学模拟。
Biophys Chem. 2020 Dec;267:106478. doi: 10.1016/j.bpc.2020.106478. Epub 2020 Sep 22.
5
In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.计算机分析与鉴定新型冠状病毒 SARS-CoV-2 的 3-糜蛋白酶样主蛋白酶的抗病毒香豆素衍生物。
Mol Divers. 2022 Apr;26(2):1053-1076. doi: 10.1007/s11030-021-10230-6. Epub 2021 Jul 2.
6
New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.新型吡唑并[1,5-a]嘧啶类化合物的合成新途径及其作为 RNA 聚合酶抑制剂的抗菌活性评价。
Med Chem. 2022;18(9):926-948. doi: 10.2174/1573406418666220302092414.
7
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.羟乙胺类似物的抗病毒评估:针对 SARS-CoV-2 主蛋白酶(3CLpro)的抑制剂,一种虚拟筛选和模拟方法。
Bioorg Med Chem. 2021 Oct 1;47:116393. doi: 10.1016/j.bmc.2021.116393. Epub 2021 Sep 4.
8
Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.甲基-β-D-吡喃半乳糖苷酯作为 SARS-CoV-2 蛋白酶抑制剂的潜力:合成、抗菌、PASS、分子对接、分子动力学模拟和量子计算。
Glycoconj J. 2022 Apr;39(2):261-290. doi: 10.1007/s10719-021-10039-3. Epub 2022 Jan 17.
9
Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (M).清洁研磨技术:含噻唑部分的腙、吡唑和吡嗪的简便合成及抗 SARS-CoV-2 主蛋白酶(M)的计算机抗病毒活性。
Molecules. 2020 Oct 6;25(19):4565. doi: 10.3390/molecules25194565.
10
Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors.新型吡唑并嘧啶酮杂环化合物 M 前体的合成及计算机对接研究作为潜在的 SARS-CoV-2 抑制剂。
Molecules. 2022 Aug 19;27(16):5303. doi: 10.3390/molecules27165303.

引用本文的文献

1
Discovery of Pyrano[2,3-]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies.吡喃并[2,3 - ]吡唑衍生物作为新型潜在人类冠状病毒抑制剂的发现:设计、合成、计算机模拟、体外及药物代谢动力学研究
Pharmaceuticals (Basel). 2024 Feb 2;17(2):198. doi: 10.3390/ph17020198.
2
Recent developments on microwave-assisted organic synthesis of nitrogen- and oxygen-containing preferred heterocyclic scaffolds.微波辅助有机合成含氮和含氧优势杂环骨架的最新进展。
RSC Adv. 2023 Nov 7;13(47):32858-32892. doi: 10.1039/d3ra05986c.
3
Discovery of Hybrid Thiouracil-Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus's Polymerase "RdRp" as a Confirmed Interacting Biomolecule.

本文引用的文献

1
Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors.新型吡唑并嘧啶酮杂环化合物 M 前体的合成及计算机对接研究作为潜在的 SARS-CoV-2 抑制剂。
Molecules. 2022 Aug 19;27(16):5303. doi: 10.3390/molecules27165303.
2
Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update.吡唑并嘧啶作为高效药物设计中有吸引力的药效团:最新进展。
Arch Pharm (Weinheim). 2022 Oct;355(10):e2200154. doi: 10.1002/ardp.202200154. Epub 2022 Jun 13.
3
Synthesis and Applications of Nitrogen-Containing Heterocycles as Antiviral Agents.
发现新型硫脲-香豆素杂合共轭物作为潜在的新型抗SARS-CoV-2药物,其靶向病毒的聚合酶“RdRp”这一已确认的相互作用生物分子。
ACS Omega. 2023 Jul 14;8(30):27056-27066. doi: 10.1021/acsomega.3c02079. eCollection 2023 Aug 1.
含氮杂环作为抗病毒药物的合成与应用。
Molecules. 2022 Apr 22;27(9):2700. doi: 10.3390/molecules27092700.
4
1-Pyrazolo[3,4-]pyridines: Synthesis and Biomedical Applications.1-吡唑并[3,4-d]嘧啶类化合物的合成及其生物医学应用
Molecules. 2022 Mar 30;27(7):2237. doi: 10.3390/molecules27072237.
5
Synthesis and crystal structures of new mixed-ligand schiff base complexes containing -donor heterocyclic co-ligands: Molecular docking and pharmacophore modeling studies on the main proteases of SARS-CoV-2 virus (COVID-19 disease).含供体杂环共配体的新型混合配体席夫碱配合物的合成与晶体结构:对严重急性呼吸综合征冠状病毒2(新冠病毒疾病)主要蛋白酶的分子对接和药效团建模研究
Polyhedron. 2022 Jul 1;220:115825. doi: 10.1016/j.poly.2022.115825. Epub 2022 Apr 4.
6
Synthetic approaches to 1,2,4-triazolo[5,1-][1,2,4]triazin-7-ones as basic heterocyclic structures of the antiviral drug Riamilovir ("Triazavirin®") active against SARS-CoV-2 (COVID-19).合成 1,2,4-三唑并[5,1-][1,2,4]三嗪-7-酮的方法,作为抗病毒药物利阿莫尔(“Triazavirin®”)的基本杂环结构,对 SARS-CoV-2(COVID-19)有效。
Org Biomol Chem. 2022 Mar 2;20(9):1828-1837. doi: 10.1039/d1ob02125g.
7
Discovery of novel pyrazolopyrimidine derivatives as potent mTOR/HDAC bi-functional inhibitors via pharmacophore-merging strategy.通过药效团融合策略发现新型吡唑并嘧啶衍生物作为有效的mTOR/HDAC双功能抑制剂
Bioorg Med Chem Lett. 2021 Oct 1;49:128286. doi: 10.1016/j.bmcl.2021.128286. Epub 2021 Jul 24.
8
COVID-19 in early 2021: current status and looking forward.2021 年初的 COVID-19:现状与展望。
Signal Transduct Target Ther. 2021 Mar 8;6(1):114. doi: 10.1038/s41392-021-00527-1.
9
Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR.基于点击化学的新型三唑并噻吩嘧啶杂合糖苷的合成、细胞毒性活性及针对 EGFR 的分子对接。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):504-516. doi: 10.1080/14756366.2020.1871335.
10
Synthesis of arylidene hydrazinylpyrido[2,3-]pyrimidin-4-ones as potent anti-microbial agents.作为强效抗菌剂的亚芳基肼基吡啶并[2,3 - ]嘧啶 - 4 - 酮的合成
Heliyon. 2020 Sep 22;6(9):e04956. doi: 10.1016/j.heliyon.2020.e04956. eCollection 2020 Sep.